After meticulously analyzing high quality data, Novumed provides access to the world’s largest pharma markets

An overview on the 200 most important pharma blockbusters helps to estimate which are the most relevant therapeutic areas and indications. High quality data was sourced from annual reviews of 2009

21-Jul-2010 - Germany

“Which are the world's 13 leading products for diabetes? How big is the market for asthma drugs based on the best selling products in this field? What was the revenue for Roche's Avastin in 2009?“ Answers to these and other questions are gathered in a study conducted by Novumed. Experts in the pharma- and biotech-sector, as well as anyone interested in the pharma business, can examine key facts regarding the pharma markets in Novumeds study database.

Novumed consultants have generated a list of the world's 200 top selling products. The combined sales of these 200 drugs are >350 billion US Dollars, representing almost 50% of the global pharma market in 2009.

All products can be sorted by various criteria such as total revenue, therapeutic area or even individual diseases (indications). For example, in the therapeutic area, such as metabolic diseases, one can access the total turnover for diabetes drugs (13 products), which in 2009 accumulated to 25 billion US Dollars. In addition to this, interesting qualitative insights into the sales figures of several companies are accessible. One can also list products of a single company, browse through the list or use free text search to find individual products. For example, Pfizer‘s best performing product (in what year?) was Lipitor (incl. Astellas) with a turnover of 12 billion US Dollars. The study is available as an applet on smart phones or online.

https://www.bionity.com/en/news/120345/after-meticulously-analyzing-high-quality-data-novumed-provides-access-to-the-worlds-largest-pharma-markets.html